Coya Therapeutics (COYA) Enterprise Value (2022 - 2026)
Coya Therapeutics (COYA) posted Enterprise Value of $94.03 million for Q2 2026, up 41.7% from $66.37 million a year earlier and up 125.5% from the prior quarter.
Powered by 
Analysis
Coya Therapeutics (COYA) Enterprise Value (2022 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Enterprise Value at Coya Therapeutics was -$31.65 million; for FY2025, it was $50.21 million, down 12.5% from FY2024.
- Annual Enterprise Value shows a three-year compound annual growth rate of 99.3% (FY2022 to FY2025).
- In prior years, Coya Therapeutics' Enterprise Value was $57.39 million in FY2024 (+34.5%), $42.69 million in FY2023 (+572.9%) and $6.34 million in FY2022.
- The Q2 2026 figure stands as the highest quarterly Enterprise Value since Q1 2024.
- On a year-over-year basis, Enterprise Value increased in five of the last eight quarters, with growth averaging 19.1%.
- The strongest year-over-year quarter for Enterprise Value in the past five years was Q4 2023, with growth of 572.9%; the weakest was Q1 2026, with a decline of 42.6%.
- According to Business Quant data, Enterprise Value for the three prior quarters was $41.7 million (Q1 2026), $50.21 million (Q4 2025) and $67.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Coya Therapeutics | 96.17 Mn | -72.70 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 94.03 Mn |
| Mar 31, 2026 | 41.70 Mn |
| Dec 31, 2025 | 50.21 Mn |
| Sep 30, 2025 | 67.30 Mn |
| Jun 30, 2025 | 66.37 Mn |
| Mar 31, 2025 | 72.68 Mn |
| Dec 31, 2024 | 57.39 Mn |
| Sep 30, 2024 | 67.08 Mn |
| Jun 30, 2024 | 55.64 Mn |
| Mar 31, 2024 | 108.96 Mn |
| Dec 31, 2023 | 42.69 Mn |
| Sep 30, 2023 | 27.31 Mn |
| Jun 30, 2023 | 27.39 Mn |
| Mar 31, 2023 | 23.17 Mn |
| Dec 31, 2022 | 6.34 Mn |
API Access
Coya Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=COYA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "COYA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=COYA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();